Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells

Clinical trial NCT05017298 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05017298
Sponsor: Celltex Therapeutics Corporation
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection Covid19

Start date: 2024-11-01
Primary completion: 2024-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.